
Maria Cecilia Lansang MD
Diabetes, Lipid Metabolism, Thyroid
Associate Professor, Medicine, Case Western Reserve Univ Sch of Med
Join to view full profile
Cleveland ClinicCleveland, OH 44195
Dr. Lansang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 2001
University of Santo TomasClass of 1992
Certifications & Licensure
OH State Medical License 2010 - 2028
PA State Medical License 2016 - 2021
FL State Medical License 2003 - 2012
MA State Medical License 2000 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- The Technologic Transformation in Diabetes Care: From Continuous Glucose Monitoring to Artificial Intelligence and Beyond.Guillermo E Umpierrez, Maria Cecilia Lansang
Endocrine Practice. 2026-02-01 - 8 citationsAttitudes and Behaviors with Diabetes Technology Use in the Hospital: Multicenter Survey Study in the United States.Nabil Z Madhun, Rodolfo J Galindo, Jessica Donato, Patricia R Hwang, Hassan F Shabir
Diabetes Technology & Therapeutics. 2023-01-01 - 9 citationsThe effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes.Sana Hasan, Mohammad Salman Khan, M Cecilia Lansang
Journal of Clinical & Translational Endocrinology. 2022-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









